Summary.-The influence of some biogenic amines and amine-receptor-blocking drugs in the growth rate of human colorectal carcinomas propagated as s.c. xenografts in immune-deprived mice was studied. In mice treated with adrenaline, a /3-adrenergic agonist, the growth of xenografts was suppressed for 2 days, after which growth was resumed at a rate similar to that in control animals. Treatment with the phosphodiesterase inhibitor theophylline prolonged the adrenaline-induced inhibition of growth. Treatment with the /-adrenergic antagonist sotalol or practolol increased the rate of tumour growth. Treatment with either serotonin or the histamine H2-receptor agonist Dimiprit had no effect on tumour growth rate. However, the antiserotoninergic drug BW 501C and the histamine H2-receptor antagonist cimetidine each caused short-term suppression of tumour growth.
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IT IS NOW well recognized that biogenic amines are able to exert short-term influences, both excitatory and inhibiting, on cell proliferation in various malignant and non-malignant tissues (Bullough & Laurence, 1966; Byron, 1972 Byron, , 1977 Epifanova & Tchoumak, 1963; Hadden et al., 1970; Hunt & Tutton, 1976; Klein, 1977; Leeson & Voaden, 1970 , Norrby, 1973 Tutton, 1974 Tutton, , 1976 Tutton & Barkla, 1976 , 1978a Tutton & Helme, 1974) . However, the influence of these ubiquitous agents on cell proliferation in human tumours and on volumetric changes in neoplasms does not appear to have been reported. Serial observations of human tumours growing as xenografts in immune-suppressed mice provide an opportunity to explore the hormonal factors controlling the progression of cancer, without the constraints necessarily surrounding human experimentation. This paper reports some preliminary observations on the influence of biogenic amines and amine-receptor-blocking drugs on the growth of human colorectal carcinomas in xenografts.
MATERIALS AND METHODS
Xenograft technique.-Female CBA/lac mice were immunosuppressed by the technique of Steel et al. (1978) . This technique involves thymectomy followed 2 weeks later by injection of cytosine arabinoside (Cytostar, the Upjohn Company) at a dose of 200 mg/kg and, after a further 24 h, the administration of 9 Gy of whole-body irradiation from a 60Co source. Pre-treatment with cytosine arabinoside obviates the need for marrow reconstitution after irradiation. Small fragments (2-3 mm in greatest linear dimension) of tumours HXK4 and HXK7 (Nowak et al., 1978) were implanted s.c. in each flank of the mice. Tumour HXK4 was originally propagated from a moderately well differentiated carcinoma of the rectosigmoid junction, and tumour HXK7 was originally propagated from a moderate to poorly differentiated carcinoma of the rectum.
Tumour measurement.-Starting on the 20th day after implantation, tumours were measured every 1-2 days. The largest and smallest superficial diameters were recorded, and the tumour volume was calculated as (mean diameter)3ii/6. The daily volume of each tumour (Vt) was divided by the volume of that tumour on the first day of measurement (VO) to obtain the relative tumour volume. The mean and s.e. of this quotient were then plotted as a function of time after the first measurement of each control and experimental group of tumours. The relative volume was calculated because inter-tumour variation in this parameter arises only during the period of measurement. The statistical significance of apparent differences between the relative volume of various groups of xenografts at a particular time after the start of treatmnent was assessed using the MannWhitney, non-parametric test for ranked observations (Sokal & Rohlf, 1969) .
The control group for Tumour HXK4 consisted of 40 xenografts and the control group for Tumour HXK7 consisted of 10, each group being measured for 12 days. The amines and amine-receptor antagonists admninistered to experimental groups of mice are listed in the Table. Each experimental group consisted of 5-6 mice bearing 9-12 xenografts. All drugs were given by i.p. injection, and all treatments began on the 20th dav after implantation.
RESULTS
The influence of adrenergic ayonists and antagonists
The administration of adrenaline, a broad-spectrum a-, /3i-and 32-adrenergic agonist, produced short-term suppression of the growth of Xenograft Line HXK4, mean tumour volume reaching a nadir on the second day of treatment (Fig. 1) . Conversely, treatment with sotalol, a 1l-and f2-adrenergic antagonist, accelerated tumour growth (Fig. 3) . The phosphodiesterase inhibitor, theophylline, prolonged the adrenaline-induced inhibition -[3-(N,N-dimethylamino) propyl]isothiourea of tumour growth ( Fig. 1) but theophylline in the absence of xenogenous adrenaline appears to have had little effect on tumour growth (Fig. 2) . Administration of terbutaline, a selective fl2-adrenergic antagonist, produced little if any inhibition of tumour growth (Fig. 3) whereas practolol, a selective /ladrenergic antagonist, promoted tumour growth to a similar extent to sotalol (Fig. 3) .
The influence of serotonergic agonist and a serotoninergic antagonist Treatment of mice with serotonin, at a dose of either 0-01 or 041 mg/kg, failed to l0 influence the rate of growth of Xenograft HXK4 (Fig. 4) . By contrast, the antiserotoninergic drug BW 501C had a small inhibitory effect on Tumour HXK4 (Fig.  5) and a greater and more prolonged inhibitory effect on Tumour HXK7 (Fig. 6) . The influence of a histamine H2-receptor agonist and a histamine H2-receptor antagonist
The histamine H2-receptor antagonist Dimiprit appeared not to influence the growth of Tumour HXK4 (Fig. 7) . However, the histamine H2-receptor antagonist cimetidine strongly inhibited the growth of Tumour HXK4 (Fig. 5) and had a slightly inhibitory effect on Tumour HXK7 (Fig. 6) possible role of cyclic nucleotides in the regulation of tumour growth; and, thirdly, the mechanism of tachyphylaxis to the growth-inhibitory agents used.
Failure of treatment with serotonin or
Dimiprit to accelerate tumour growth may be a feature of the doses used. In earlier experiments on the influence of serotonin on cell proliferation it was found that the effect of this agent was highly dosedependent, low doses promoting cell division whilst higher doses were ineffective or inhibitory (Tutton, 1974; Tutton & Barkla, 1978a) . In the case of histaminic agonists, specific desensitization of receptors may rapidly follow exposure of cells to high levels of stimulants (Barsoum & Gaddum, 1935) . Alternatively, tumour growth may already be maximally stimulated by endogenous histamine or serotonin.
Cyclic nucleotides have now been implicated in the control of proliferation in a vast array of cell types. High intracellular levels of cyclic guanosine monophosphate (cGMP) or treatment with agents that promote the formation of cGMP are associated with rapid cell division in bacteria (Benlohr et al., 1974) , meristematic plant cells and mammalian fibroblasts , haemopoietic stem cells (Byron, 1974) , lymphocytes (Hadden et al., 1970) , granulocyte-macrophage progenitor cells (Kurland et al., 1977) , epidermal cells (Voorhees et al., 1973) and intestinal epithelial cells (Tutton, 1976) . Cyclic adenosine monophosphate (cAMP), on the other hand, has been shown to inhibit division in many cell types (for a review see Whitfield et al., 1976) and is an important mediator in the process of contact inhibition of cell division (Pastan et al., 1973 permanently suppressed, tumour growth will be resumed because of relative expansion of the subpopulation of resistant cells. Pharmacological factors that could feasibly be responsible for the observed tachyphylaxis include changes in receptor sensitivity or change in the activity of the phosphodiesterases which are responsible for degrading cyclic nucleotides. Changes in receptor sensitivity after administration of amines has been most extensively studied with respect to the influence of /-adrenergic agonists on adenyl cyclase activity. In this system desensitization due to reduction in the number of functioning drug receptors (Mukherjee et al., 1975; Mickey et al., 1975) , reduction in receptor affinity (Lin et al., 1977) and negative receptor-receptor cooperation (Limbird et al., 1975) have been demonstrated. In addition to membrane receptor changes, tachyphylaxis may be mediated by a specific cAMP-phosphodiesterase, the synthesis of which is induced by high intracellular levels of cAMP (Appleman & Terasaki, 1975) . The latter explanation does appear to be relevant, at least for the observed tachyphylaxis to adrenaline, since a phosphodiesterase inhibitor prolonged the suppressive effect of this amine.
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